CL2004001034A1 - Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r - Google Patents
Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, rInfo
- Publication number
- CL2004001034A1 CL2004001034A1 CL200401034A CL2004001034A CL2004001034A1 CL 2004001034 A1 CL2004001034 A1 CL 2004001034A1 CL 200401034 A CL200401034 A CL 200401034A CL 2004001034 A CL2004001034 A CL 2004001034A CL 2004001034 A1 CL2004001034 A1 CL 2004001034A1
- Authority
- CL
- Chile
- Prior art keywords
- etilbenzotiofen
- iltio
- benzimidazol
- butanoic
- til
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003135567 | 2003-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004001034A1 true CL2004001034A1 (es) | 2005-03-28 |
Family
ID=33447189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200401034A CL2004001034A1 (es) | 2003-05-14 | 2004-05-13 | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |
Country Status (25)
Country | Link |
---|---|
US (1) | US7649008B2 (es) |
EP (1) | EP1626048A4 (es) |
JP (1) | JPWO2004101551A1 (es) |
KR (1) | KR20060011997A (es) |
CN (1) | CN1788007A (es) |
AR (1) | AR044340A1 (es) |
AU (1) | AU2004238708A1 (es) |
BR (1) | BRPI0410266A (es) |
CA (1) | CA2523978A1 (es) |
CL (1) | CL2004001034A1 (es) |
CO (1) | CO5660259A2 (es) |
EC (1) | ECSP056162A (es) |
IS (1) | IS8177A (es) |
MA (1) | MA27805A1 (es) |
MX (1) | MXPA05011851A (es) |
NO (1) | NO20055181L (es) |
NZ (1) | NZ542978A (es) |
PE (1) | PE20050203A1 (es) |
RU (1) | RU2332417C2 (es) |
SA (1) | SA04250117B1 (es) |
TN (1) | TNSN05288A1 (es) |
TW (1) | TW200505911A (es) |
UA (1) | UA81493C2 (es) |
WO (1) | WO2004101551A1 (es) |
ZA (1) | ZA200508640B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2004001034A1 (es) | 2003-05-14 | 2005-03-28 | Teijin Pharma Ltd | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |
CA2536435A1 (en) * | 2003-08-22 | 2005-03-03 | Teijin Pharma Limited | Drug containing chymase inhibitor as the active ingredient |
EP1826207A4 (en) * | 2004-11-12 | 2009-05-20 | Teijin Pharma Ltd | ACID SALT OF A BENZIMIDAZOLE DERIVATIVE AND CRYSTAL THEREOF |
JP2016150917A (ja) * | 2015-02-17 | 2016-08-22 | 株式会社トクヤマ | バルサルタンの結晶の製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3683760D1 (de) | 1986-03-21 | 1992-03-12 | Heumann Pharma Gmbh & Co | Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung. |
US5015646A (en) | 1987-08-28 | 1991-05-14 | Bristol-Myers Squibb Co. | Pharmaceutically useful polymorphic modification of buspirone |
AU687202B2 (en) | 1994-05-31 | 1998-02-19 | Teijin Limited | Naphthalene derivative |
ES2150353B1 (es) | 1998-04-15 | 2001-07-01 | Esteve Labor Dr | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. |
US20040010004A1 (en) * | 2000-01-17 | 2004-01-15 | Naoki Tsuchiya | Benzimidazole derivatives |
TR200100047T2 (tr) | 1998-07-15 | 2001-10-22 | Teijin Limited | Tiyobenzimidazol türevleri |
CN1198819C (zh) | 2000-01-17 | 2005-04-27 | 帝人株式会社 | 苯并咪唑衍生物 |
ATE376830T1 (de) * | 2001-02-22 | 2007-11-15 | Teijin Pharma Ltd | Benzo(b(thiophenderivate und verfahren zu deren herstellung |
JP3999131B2 (ja) * | 2001-05-07 | 2007-10-31 | 帝人株式会社 | 3−ヒドロキシメチル−ベンゾ[b]チオフェン誘導体、及びその製造方法 |
JP4173098B2 (ja) * | 2001-08-24 | 2008-10-29 | 帝人株式会社 | キマーゼ阻害剤及びace阻害剤を有効成分として含有する薬剤 |
CL2004001034A1 (es) | 2003-05-14 | 2005-03-28 | Teijin Pharma Ltd | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |
-
2004
- 2004-05-13 CL CL200401034A patent/CL2004001034A1/es unknown
- 2004-05-14 RU RU2005138868/04A patent/RU2332417C2/ru not_active IP Right Cessation
- 2004-05-14 US US10/556,683 patent/US7649008B2/en not_active Expired - Fee Related
- 2004-05-14 UA UAA200511908A patent/UA81493C2/xx unknown
- 2004-05-14 KR KR1020057021506A patent/KR20060011997A/ko not_active Application Discontinuation
- 2004-05-14 NZ NZ542978A patent/NZ542978A/en unknown
- 2004-05-14 JP JP2005506263A patent/JPWO2004101551A1/ja not_active Ceased
- 2004-05-14 PE PE2004000502A patent/PE20050203A1/es not_active Application Discontinuation
- 2004-05-14 WO PCT/JP2004/006887 patent/WO2004101551A1/ja active Application Filing
- 2004-05-14 CN CNA2004800127952A patent/CN1788007A/zh active Pending
- 2004-05-14 AR ARP040101656A patent/AR044340A1/es unknown
- 2004-05-14 AU AU2004238708A patent/AU2004238708A1/en not_active Abandoned
- 2004-05-14 TW TW093113785A patent/TW200505911A/zh unknown
- 2004-05-14 CA CA002523978A patent/CA2523978A1/en not_active Abandoned
- 2004-05-14 BR BRPI0410266-5A patent/BRPI0410266A/pt not_active IP Right Cessation
- 2004-05-14 EP EP04733128A patent/EP1626048A4/en not_active Withdrawn
- 2004-05-14 MX MXPA05011851A patent/MXPA05011851A/es unknown
- 2004-05-15 SA SA4250117A patent/SA04250117B1/ar unknown
-
2005
- 2005-10-25 ZA ZA200508640A patent/ZA200508640B/en unknown
- 2005-11-03 NO NO20055181A patent/NO20055181L/no not_active Application Discontinuation
- 2005-11-11 CO CO05115024A patent/CO5660259A2/es not_active Application Discontinuation
- 2005-11-14 EC EC2005006162A patent/ECSP056162A/es unknown
- 2005-11-14 MA MA28603A patent/MA27805A1/fr unknown
- 2005-11-14 TN TNP2005000288A patent/TNSN05288A1/en unknown
- 2005-12-13 IS IS8177A patent/IS8177A/is unknown
Also Published As
Publication number | Publication date |
---|---|
CN1788007A (zh) | 2006-06-14 |
MXPA05011851A (es) | 2006-02-17 |
JPWO2004101551A1 (ja) | 2006-07-13 |
EP1626048A4 (en) | 2008-11-12 |
MA27805A1 (fr) | 2006-03-01 |
RU2005138868A (ru) | 2006-07-10 |
TW200505911A (en) | 2005-02-16 |
NO20055181D0 (no) | 2005-11-03 |
RU2332417C2 (ru) | 2008-08-27 |
CO5660259A2 (es) | 2006-07-31 |
CA2523978A1 (en) | 2004-11-25 |
US20060293375A1 (en) | 2006-12-28 |
KR20060011997A (ko) | 2006-02-06 |
NO20055181L (no) | 2006-01-24 |
AU2004238708A1 (en) | 2004-11-25 |
PE20050203A1 (es) | 2005-03-26 |
BRPI0410266A (pt) | 2006-05-16 |
WO2004101551A1 (ja) | 2004-11-25 |
EP1626048A1 (en) | 2006-02-15 |
UA81493C2 (en) | 2008-01-10 |
NZ542978A (en) | 2009-04-30 |
US7649008B2 (en) | 2010-01-19 |
ECSP056162A (es) | 2006-04-19 |
SA04250117B1 (ar) | 2009-09-02 |
TNSN05288A1 (en) | 2007-07-10 |
IS8177A (is) | 2005-12-13 |
ZA200508640B (en) | 2007-02-28 |
AR044340A1 (es) | 2005-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055316D0 (no) | Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike | |
CL2006001266A1 (es) | Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas. | |
CL2003002353A1 (es) | Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic | |
CY1112653T1 (el) | Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης | |
CL2007002450A1 (es) | Forma polimorfica i del enantiomero levogiro o dextrogiro de modafinilo; su procedimiento de preparacion; y composicion farmaceutica que los comprende (divisional solicitud 2693-03). | |
UY30327A1 (es) | Nuevos compuestos ii | |
ATE517085T1 (de) | Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate | |
DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
UY30728A1 (es) | Sales y formas de cristal del 2-metil-[4-(3-metil-2-oxo-8-quinolin-3-il-2,3-dihidro-imidazo-[4,5-c]-quinolin-1-il-fenil]propionitrilo | |
PA8586001A1 (es) | Derivados de indol útiles para el tratamiento de enfermedades | |
CL2008001818A1 (es) | Ácido {4,6-bis(dimetilamino)-2-(4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il}acético amorfo y sus formas cristalinas i y ii; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias tales como asma, rinitis alérgica, crohn, entre otras. | |
BRPI0507877A (pt) | derivados de formamida, composição farmacêutica, uso dos mesmos e combinação | |
BRPI0507041A (pt) | composto derivados de sulfonamida para o tratamento de doenças seus usos, processo para a preparação dos compostos e combinação de compostos | |
NO20084328L (no) | Nye forbindelser | |
DOP2011000360A (es) | Sales de disacarina, acido difumarico, acido di-1-hidroxi-2-naftoico y acido monobenzoico de 2-(4((2-amino-4-metil-6-(pentilamino) primidin-5-ii)metil) fenil) acetato de 4-(dimetilamino) butilo | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
CL2011003144A1 (es) | Forma cristalina e3 de bisulfato de atazanavir; composicion farmaceutica que la comprende; util para el tratamiento de enfermedades originadas por retrovirus (divisional de la solicitud 1057-05). | |
BRPI0816904B8 (pt) | Forma cristalna b da forma sólida do sal de bis-hcl, composição farmacêutica, e, uso de uma forma sólida | |
NO20074648L (no) | 5-fenyl-pentansyrederivater som matrise metalloproteinaseinhibitorer til behandling av astma og andre sykdommer | |
PA8566601A1 (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
DK1492773T3 (da) | 4-(Heterocyclyl)-benzensulfoximin-forbindelser til behandling af inflammation | |
BRPI0514111B8 (pt) | derivados de benzamidina, processo para a preparação destes e composição farmacêutica compreendendo os mesmos | |
NO20071805L (no) | Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere. | |
DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
CL2004001034A1 (es) | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |